NCT06275841View on ClinicalTrials.gov

A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

May 3, 2024

Study Completion Date

May 24, 2024

Conditions
Healthy
Interventions
DRUG

vepdegestrant

experimental

DRUG

esomeprazole

Experimental treatment to assess an endpoint

Trial Locations (1)

06511

Pfizer Clinical Research Unit - New Haven, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

Arvinas Estrogen Receptor, Inc.

INDUSTRY

lead

Pfizer

INDUSTRY

NCT06275841 - A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant | Biotech Hunter | Biotech Hunter